Bringing Hope and Care Closer to Home: Improving Accessibility for Lung Cancer Treatments
October 30, 2025 | 1:00 – 2:30 p.m. ET
Should a person’s postal code affect their lung cancer outcomes? Or could breakthroughs translate into equitable access and improved outcomes for all patients, no matter where they live?
For too many Canadians, access to life-saving lung cancer treatments is shaped by geography and systemic barriers rather than medical need. Yet advances in clinical trials and subcutaneous therapies that can replace some IV infusions offer a chance to transform care—making treatments faster, more convenient, and closer to home.
During this policy forum, we will:
- Analyze disparities in lung cancer treatment access across Canada by examining how geography, infrastructure, and socio-economic factors contribute to inequitable care, particularly in rural, remote, and underserved communities.
- Introduce the Canadian Remote Access Framework for Clinical Trials (CRAFT) pilot, highlighting its design, early outcomes, and potential to reshape how clinical trials are delivered across regions with limited specialist access.
- Showcase innovative, patient-centered care models—including home- and community-administered therapies such as subcutaneous treatments—that reduce the burden of travel and enable patients to receive high-quality care closer to home.
- Explore the broader health system and economic implications of decentralizing cancer care, including cost-effectiveness, workforce capacity, and opportunities to strengthen health equity through policy and investment.
